Dara BioSciences, Helsinn Group sales and marketing update

Helsinn granted Dara exclusive, U.S. rights to commercialize Gelclair povidone. The bioadherent oral gel is approved in the U.S. to treat oral mucositis. Dara plans to launch Gelclair in 1Q13. Dara and Helsinn declined to disclose financial details. ...